Acute myeloïde leukemie (AML)
NK4AML: Infusion of ex vivo-generated allogeneic natural killer cells in combination with subcutaneous IL-2 in patients with acute myeloid leukemia: a phase I/IIa study
Myelodysplastisch syndroom (MDS)
IMerge 2: A study to evaluate imetelstat (GRN163L) in transfusion-dependent subjects with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed/refractory to erythropoiesis-stimulating agent (ESA) treatment
Supportive care
REDDS2: A randomised feasibility n-of-1 trial of weekly-interval red cell transfusion in myelodysplastic syndrome
DUET2: Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial
ReSPECT: A phase 3, multicenter, randomized, double-blind study of the efficacy and safety of rezafungin for injection versus the standard antimicrobial regimen to prevent invasive fungal diseases in adults undergoing allogeneic blood and marrow transplantation
Stolling
TAP-100: Validation TAP-100 blood collection device
HISTORY: Hypoplasminogenemia: an international retrospective and prospective cohort study
OPTI-CLOT: To WiN: Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand disease
Hemoglobinopathie
SCORE: Sickle cell outcome research
Sickle cell screen: Investigating red blood cell deformability of sickle cell patients before and after the start of therapy
Ga terug naar de algemene homepage Studieprotocollen.